ThisCART19A is under clinical development by Suzhou Fundamenta Therapeutics and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia.
Experts Discuss the Latest Studies on ADCs for Lung Cancer at ASCO 2024
In a comprehensive discussion on the role of antibody-drug conjugates (ADCs) in the treatment of lung cancer at the American Society of Clinical Oncology (ASCO)